Space Exploration Technologies (SpaceX) stock broke below its $135 IPO price on July 15, 2026, marking a roughly 40% decline from its post-IPO high of $225 just weeks after the historic listing. The selloff has been driven by a combination of Morgan Stanley’s warning of a $672 billion funding requirement with no projected positive cash flow until 2035, mounting short seller pressure, and growing concern over a potential 900% float explosion when lockups expire starting in August. Despite the carnage, Needham raised its price target to $250 on July 15, and Cathie Wood’s Ark Invest bought $16.6 million in shares on the dip.
Key Drivers of the SPCX Stock Move
- Catalyst: SPCX slipped below its $135 IPO price for the first time on July 15, triggering a fresh wave of bearish options flow and media scrutiny. The break coincided with a renewed analyst warning that the company will not turn profitable until at least 2027, and short sellers piling in as the lockup expiration timeline looms.
- Bull Case: Wall Street’s initiation coverage wave was overwhelmingly bullish. Morgan Stanley targets $300, BofA $235, Bernstein $239, Deutsche Bank $255, and Cantor Fitzgerald $246. Cathie Wood has now purchased over $70 million in SPCX shares across multiple dip-buying sessions. Starlink’s airline partnership expansion (American, United, Frontier) and the FCC’s accelerated satellite licensing process offer tangible near-term revenue catalysts.
- Bear Case: CFRA has a Sell rating with a $115 target, MoffettNathanson sits at $131 (Neutral), and Gary Black openly holds zero SPCX. Morgan Stanley’s own research flags a $672 billion funding requirement with no positive cash flow until 2035. George Noble warns that a 900% float expansion from lockup expirations could overwhelm any demand support. Jeremy Grantham has called this IPO the “craziest ever.”
The setup is a textbook post-IPO repricing with structural headwinds. SPCX entered the Nasdaq-100 on July 7, forcing an estimated $4.3 billion in passive inflows, yet the stock still finished that day lower. The $25 billion unsecured bond raise completed in June adds significant leverage to a company with no current positive cash flow. The August lockup expiration is the single biggest near-term overhang, with early institutional backers sitting on massive gains from pre-IPO prices and facing the first real exit window.
Post-IPO Selling Pressure Intensifies
SpaceX shares slipped below their $135 IPO price for the first time on July 15, extending their losing streak to four consecutive sessions and highlighting how quickly post-IPO enthusiasm has faded. The stock has been highly volatile since its record-breaking June debut, briefly rallying above $225 before retreating to around $135. Investors are now shifting their focus from IPO momentum to longer-term fundamentals, with the upcoming Starship test flight serving as the next major operational catalyst. Despite recently joining the Nasdaq-100 and benefiting from passive index inflows, the stock has continued to weaken, underscoring growing caution around SpaceX’s valuation and execution outlook.
SPCX Smart Money Activity
Congressional buying has been a notable feature of the SPCX story, with four House members disclosing purchases between June 12 and June 18 near the $160-$185 range. John James (R), Daniel Meuser (R), and John McGuire (R) each bought, along with Gilbert Cisneros (D). All four trades are currently underwater by 17% to 29% based on current prices, drawing scrutiny given that McGuire and James sit on committees with defense and aerospace oversight. No insider trade filings have been reported since the IPO.
SPCX Unusual Options
Options flow on July 15 was decisively bearish as the stock broke below IPO price. The single largest print was a $3.4 million sweep on the Dec ’26 $205 PUT, tagged bearish above the ask. A $2.0 million bearish sweep hit the Sep ’26 $130 PUT, and a $1.5 million sweep targeted the Jan ’27 $95 PUT. A cluster of Aug ’26 puts ($110 strike, $120 strike) drew over $750K in combined premium. The only notable bullish outlier was a $460.6K bearish-tagged sweep on Aug ’26 $150 PUTs placed at the ask, reinforcing downside hedging sentiment. Overall put premium dominated the session, signaling that institutional traders were actively protecting against further downside below the IPO price floor.
SPCX Analyst Focus
With SPCX a freshly minted public company, all coverage is initial. The bull camp is broad and includes Morgan Stanley ($300), Deutsche Bank ($255), Bank of America ($235), Cantor Fitzgerald ($246), Bernstein ($239), Macquarie ($250), Needham ($250, raised July 15), JP Morgan ($225), RBC Capital ($225), Wells Fargo ($230), Goldman Sachs ($205), UBS ($210), and Citigroup ($200). The bear/neutral camp includes CFRA (Sell, $115), MoffettNathanson (Neutral, $131), Susquehanna (Neutral, $170), Daiwa Capital (Neutral, $175), Keybanc (Hold), and Argus Research (Hold). The buy-side median price target sits near ~$225, implying roughly 66% upside from current levels if the bulls are right. The spread between the most bearish ($115) and the most bullish (Raymond James, $800) underscores how wide the valuation uncertainty remains.
SPCX Seasonality
SPCX only went public in June 2026, so there is no meaningful multi-year seasonality data available. With just one month of trading history, any monthly pattern would be statistically meaningless. The single data point shows July is -20.8% month-to-date (1 sample). Investors should not draw seasonal conclusions until the company accumulates several years of trading history.
SPCX Relative Performance
SPCX has declined approximately 16% from its June 12 close of $160.95 to $135.27 as of July 15, and is down roughly 40% from its all-time high of $225 set shortly after IPO. For context, peer space names have seen diverging performance: RKLB (Rocket Lab) climbed nearly 3% in pre-market on July 14 after a successful Neutron engine test, while Redwire gained earlier in the month on defense contract wins before giving back ground. SPCX has underperformed the broader space sector since its IPO peak, and has tracked broadly in line with growth stock weakness, though the magnitude of the drawdown from highs is notably severe even by high-beta standards.
Market Update Into September 14th: Rate Hike Incoming?